Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations

Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations

Abstract Background Time to deterioration (TTD) endpoints are often utilized in the analysis of patient-reported outcome (PRO) data in oncology clinical trials but different endpoint definitions and analysis frameworks exist that can impact result interpretation. This review examined the analysis, r...

Full description

Bibliographic Details
Main Authors: Kim Cocks, Bellinda L. King-Kallimanis, Joel Sims, Gill Worthy, Julia Stein, Lara Ayala–Nunes, Monika Achra, Zhanglin Lin Cui, Nalin Payakachat
Format: Article
Language:English
Published: SpringerOpen 2024-12-01
Series:Journal of Patient-Reported Outcomes
Subjects:
Patient reported outcome
Neoplasms
Endpoint determination
Survival analysis
Randomized controlled trials
Review literature
Online Access:https://doi.org/10.1186/s41687-024-00824-7

Internet

https://doi.org/10.1186/s41687-024-00824-7

Similar Items